Literature DB >> 3122254

Interaction between chronic amphetamine and neuroleptic treatments on oral behavior in rats.

A D Levy1, G D Ellison.   

Abstract

The interaction of concurrently administered amphetamine (AMPH) and haloperidol (HAL) on behavior was examined. Rats were divided into four groups: drug naive controls; HAL-treated for 6 months; AMPH-treated for 1 month; and rats administered both continuous HAL for 6 months and concurrent AMPH treatment during the 2nd month of HAL administration. AMPH alone increased locomotor activity, and this effect was blocked by concurrent haloperidol administration; however, the AMPH-induced reduction of body weight was unaltered by concurrent haloperidol treatment. Oral behavior, monitored both by a human observer and a computerized system, was not significantly altered by HAL alone, or by AMPH alone, but increases in tremorous oral behavior appeared in the concurrent administration group 4 months after AMPH treatment was discontinued. These results could have implications for tardive dyskinesia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122254     DOI: 10.1007/bf00179937

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model.

Authors:  L A Rodriguez; D E Moss; E Reyes; M L Camarena
Journal:  Pharmacol Biochem Behav       Date:  1986-12       Impact factor: 3.533

2.  Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.

Authors:  R M Allen
Journal:  Biol Psychiatry       Date:  1982-06       Impact factor: 13.382

3.  Induction of oral dyskinesias in naive rats by D1 stimulation.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1983-12-19       Impact factor: 5.037

4.  Drug holidays alter onset of oral movements in rats following chronic haloperidol.

Authors:  W W Sant; G Ellison
Journal:  Biol Psychiatry       Date:  1984-01       Impact factor: 13.382

5.  Continuous amphetamine intoxication: an animal model of the acute psychotic episode.

Authors:  G D Ellison; M S Eison
Journal:  Psychol Med       Date:  1983-11       Impact factor: 7.723

6.  Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.

Authors:  S J List; P Seeman
Journal:  Life Sci       Date:  1979-04-16       Impact factor: 5.037

Review 7.  Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

Authors:  J M Kane; J M Smith
Journal:  Arch Gen Psychiatry       Date:  1982-04

8.  Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.

Authors:  J L Waddington; H A Youssef; A G Molloy; K M O'Boyle; M T Pugh
Journal:  J Clin Psychiatry       Date:  1985-04       Impact factor: 4.384

9.  Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.

Authors:  A J Friedhoff; K Bonnet; H Tosengarten
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-03

Review 10.  Acute dystonia induced by neuroleptic drugs.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more
  2 in total

Review 1.  Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

Authors:  J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Dyskinesias possibly induced by norpseudoephedrine.

Authors:  A Thiel; D Dressler
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.